Corgenix Med Corp (CONX)

Currency in USD
0.264
0.000(0.00%)
Closed·
Showing Corgenix Med Corp historical data. For real-time data please try another search
Day's Range
0.2640.275
52 wk Range
0.0000.275
Key Statistics
Prev. Close
0.264
Open
0.27
Day's Range
0.264-0.275
52 wk Range
0-0
Volume
-
Average Volume (3m)
269.19K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Corgenix Med Corp News & Analysis

Show more

Corgenix Med Corp Company Profile

Corgenix Medical Corporation is engaged in the research, development, manufacture, and marketing of in vitro diagnostic (IVD) products for use in disease detection and diagnosis in North America and internationally. It provides Microplate Enzyme Linked ImmunoSorbent Assay (ELISA) tests; vascular disease products, such as antiphospholipid antibody testing products; and products that are used in the diagnosis of bleeding and clotting disorders, including von Willebrand’s disease (hemophilia B). The company also provides the AspirinWorks test kit, a urine test that measures aspirin dosage; and products for liver disease. In addition, it offers contract manufacturing services to other diagnostic and life science companies, as well as contract product development services to strategic partners and alliances; and purchases and resells IVD products, instruments, instrument systems, and various reagents and supplies. The company manufactures and sells approximately 50 diagnostic products to hospitals, clinical testing laboratories, universities, biotechnology and pharmaceutical companies, and research institutions through a network of sales representatives, independent distributors, and private label agreements. Corgenix Medical Corporation has a strategic collaboration with Tulane University, and other industry and academic partners to develop a group of products to detect viruses identified as potential bio-terrorism agents. The company was founded in 1985 and is headquartered in Broomfield, Colorado. As of March 10, 2015, Corgenix Medical Corp. operates as a subsidiary of ORGENTEC Diagnostika GmbH.

Earnings

Latest Release
Feb 13, 2015
EPS / Forecast
0.01 / --
Revenue / Forecast
3.63M / --
EPS Revisions
Last 90 days

CONX Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.